[go: up one dir, main page]

CA2198092A1 - Systeme therapeutique transdermique avec protection contre l'hydrolyse - Google Patents

Systeme therapeutique transdermique avec protection contre l'hydrolyse

Info

Publication number
CA2198092A1
CA2198092A1 CA002198092A CA2198092A CA2198092A1 CA 2198092 A1 CA2198092 A1 CA 2198092A1 CA 002198092 A CA002198092 A CA 002198092A CA 2198092 A CA2198092 A CA 2198092A CA 2198092 A1 CA2198092 A1 CA 2198092A1
Authority
CA
Canada
Prior art keywords
therapeutic system
transdermal therapeutic
protection against
against hydrolysis
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002198092A
Other languages
English (en)
Other versions
CA2198092C (fr
Inventor
Hanshermann Franke
Michael Horstmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4429663A external-priority patent/DE4429663C2/de
Application filed by Individual filed Critical Individual
Publication of CA2198092A1 publication Critical patent/CA2198092A1/fr
Application granted granted Critical
Publication of CA2198092C publication Critical patent/CA2198092C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002198092A 1994-08-20 1995-08-12 Systeme therapeutique transdermique avec protection contre l'hydrolyse Expired - Fee Related CA2198092C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4429663A DE4429663C2 (de) 1994-08-20 1994-08-20 Transdermales therapeutisches System mit Hydrolyseschutz
DEP4429663.0 1994-08-20
PCT/EP1995/003204 WO1996006600A1 (fr) 1994-08-20 1995-08-12 Systeme therapeutique transdermique protege contre l'hydrolyse

Publications (2)

Publication Number Publication Date
CA2198092A1 true CA2198092A1 (fr) 1996-03-07
CA2198092C CA2198092C (fr) 2005-10-25

Family

ID=35311703

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002198092A Expired - Fee Related CA2198092C (fr) 1994-08-20 1995-08-12 Systeme therapeutique transdermique avec protection contre l'hydrolyse

Country Status (1)

Country Link
CA (1) CA2198092C (fr)

Also Published As

Publication number Publication date
CA2198092C (fr) 2005-10-25

Similar Documents

Publication Publication Date Title
AU6641496A (en) Active matrix esd protection and testing scheme
WO1997004818A3 (fr) Systeme therapeutique transdermique pour administrer des constituants actifs au corps humain par voie cutanee
WO1998030203A3 (fr) Systeme therapeutique transdermique
WO2002003969A3 (fr) Systeme therapeutique transdermique contenant du dioxyde de silicium fortement disperse
CA2276445A1 (fr) Systeme therapeutique transdermique pour administrer des hormones
AU6021198A (en) Improved active matrix esd protection and testing scheme
IL106512A (en) Plaster for the transdermal application of steroid hormones and process for the preparation thereof
CA2278639A1 (fr) Systeme a emplatre transdermique ou topique avec matrice au polyacrylate a proprietes physiques ameliorees
MY111688A (en) Transdermal therapeutic system comprising the active substance 17-b-estradiol (anhydous)
CA2387143A1 (fr) Systeme therapeutique transdermique a base d'hydrochlorure de tulobuterol utilise pour administrer le bronchodilatateur tulobuterol par l'intermediaire de la peau
FR2754740B1 (fr) Composite actif a structure feuilletee comprenant un agent actif sous forme de granules
IE900212L (en) Superficial therapeutic system comprising an antineoplastic¹active substance, particularly 5-fluorouracil
DE59509643D1 (de) Transdermales therapeutisches system mit hydrolyseschutz
CA2198092A1 (fr) Systeme therapeutique transdermique avec protection contre l'hydrolyse
WO1999007349A3 (fr) Systeme therapeutique transdermique (tts) permettant d'introduire un principe actif dans un organisme par la peau et procede d'application sur la peau
MX9701302A (es) Sistema terapeutico transdermico de estradiol que comprende aditivos higroscopicos.
CA2197865A1 (fr) Systeme therapeutique transdermique renfermant de l'oestradiol et des additifs hydrophiles
WO1997021430A3 (fr) Preparation pharmaceutique a surface stabilisee pour application sur la peau
CA2370023A1 (fr) Systeme therapeutique transdermique contenant un neuroleptique tres actif
WO1996008237A3 (fr) Pansement auto-adhesif pour liberation d'un principe actif dans l'environnement d'un support
CA2147274A1 (fr) Dispositif d'administration transdermique de physostigmine et methode de fabrication de ce dispositif
CA2197867A1 (fr) Systeme therapeutique transdermique renfermant de l'oestradiol et des additifs hydrophiles
ITMI950707A0 (it) Composti azolici ad attivita' antimicotica per uso umano e veterinario
CA2172401A1 (fr) Systeme therapeutique transdermique avec l'acide acetylsalicylique comme substance active
HK1026846A (en) Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20140812